BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 18440459)

  • 1. Repeat radiofrequency ablation for local progression of lung tumors: does it have a role in local tumor control?
    Hiraki T; Mimura H; Gobara H; Sano Y; Fujiwara H; Date H; Kanazawa S
    J Vasc Interv Radiol; 2008 May; 19(5):706-11. PubMed ID: 18440459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for local progression after percutaneous radiofrequency ablation of lung tumors: evaluation based on a preliminary review of 342 tumors.
    Hiraki T; Sakurai J; Tsuda T; Gobara H; Sano Y; Mukai T; Hase S; Iguchi T; Fujiwara H; Date H; Kanazawa S
    Cancer; 2006 Dec; 107(12):2873-80. PubMed ID: 17096433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency and risk factors of various complications after computed tomography-guided radiofrequency ablation of lung tumors.
    Okuma T; Matsuoka T; Yamamoto A; Oyama Y; Toyoshima M; Nakamura K; Inoue Y
    Cardiovasc Intervent Radiol; 2008; 31(1):122-30. PubMed ID: 17985181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiofrequency ablation for the treatment of unresectable lung metastases in patients with colorectal cancer: a multicenter study in Japan.
    Yamakado K; Hase S; Matsuoka T; Tanigawa N; Nakatsuka A; Takaki H; Takao M; Inoue Y; Kanazawa S; Inoue Y; Sawada S; Kusunoki M; Takeda K
    J Vasc Interv Radiol; 2007 Mar; 18(3):393-8. PubMed ID: 17377185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous radiofrequency ablation for clinical stage I non-small cell lung cancer: results in 20 nonsurgical candidates.
    Hiraki T; Gobara H; Iishi T; Sano Y; Iguchi T; Fujiwara H; Tajiri N; Sakurai J; Date H; Mimura H; Kanazawa S
    J Thorac Cardiovasc Surg; 2007 Nov; 134(5):1306-12. PubMed ID: 17976467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors influencing the development of an iatrogenic pneumothorax for computed tomography-guided radiofrequency ablation of upper renal tumor.
    Park BK; Kim CK
    Acta Radiol; 2008 Dec; 49(10):1200-6. PubMed ID: 19031183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates.
    Fernando HC; De Hoyos A; Landreneau RJ; Gilbert S; Gooding WE; Buenaventura PO; Christie NA; Belani C; Luketich JD
    J Thorac Cardiovasc Surg; 2005 Mar; 129(3):639-44. PubMed ID: 15746749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiofrequency ablation for the treatment of stage I non-small cell lung cancer in high-risk patients.
    Pennathur A; Luketich JD; Abbas G; Chen M; Fernando HC; Gooding WE; Schuchert MJ; Gilbert S; Christie NA; Landreneau RJ
    J Thorac Cardiovasc Surg; 2007 Oct; 134(4):857-64. PubMed ID: 17903496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung radiofrequency ablation in patients with pulmonary metastases from musculoskeletal sarcomas [corrected].
    Nakamura T; Matsumine A; Yamakado K; Matsubara T; Takaki H; Nakatsuka A; Takeda K; Abo D; Shimizu T; Uchida A
    Cancer; 2009 Aug; 115(16):3774-81. PubMed ID: 19514086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation.
    Komorizono Y; Oketani M; Sako K; Yamasaki N; Shibatou T; Maeda M; Kohara K; Shigenobu S; Ishibashi K; Arima T
    Cancer; 2003 Mar; 97(5):1253-62. PubMed ID: 12599233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective study of a 'popping' sound during percutaneous radiofrequency ablation for hepatocellular carcinoma.
    Fernandes ML; Lin CC; Lin CJ; Chen WT; Lin SM
    J Vasc Interv Radiol; 2010 Feb; 21(2):237-44. PubMed ID: 20031448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors contributing to cavitation after CT-guided percutaneous radiofrequency ablation for lung tumors.
    Okuma T; Matsuoka T; Yamamoto A; Oyama Y; Inoue K; Nakamura K; Inoue Y
    J Vasc Interv Radiol; 2007 Mar; 18(3):399-404. PubMed ID: 17377186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extending indications for radiofrequency ablation of lung tumors through an intraoperative approach.
    Linden PA; Wee JO; Jaklitsch MT; Colson YL
    Ann Thorac Surg; 2008 Feb; 85(2):420-3. PubMed ID: 18222236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous radiofrequency ablation of renal tumors: midterm results in 16 patients.
    Memarsadeghi M; Schmook T; Remzi M; Weber M; Pötscher G; Lammer J; Kettenbach J
    Eur J Radiol; 2006 Aug; 59(2):183-9. PubMed ID: 16725292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiofrequency ablation with internally cooled versus perfused electrodes for the treatment of small hepatocellular carcinoma in patients with cirrhosis.
    Seror O; N'Kontchou G; Tin-Tin-Htar M; Barrucand C; Ganne N; Coderc E; Trinchet JC; Sellier N; Beaugrand M
    J Vasc Interv Radiol; 2008 May; 19(5):718-24. PubMed ID: 18440461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous radiofrequency thermoablation as an alternative to surgery for treatment of liver tumour recurrence after hepatectomy.
    Elias D; De Baere T; Smayra T; Ouellet JF; Roche A; Lasser P
    Br J Surg; 2002 Jun; 89(6):752-6. PubMed ID: 12027986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protecting the ureter during radiofrequency ablation of renal cell cancer: a pilot study of retrograde pyeloperfusion with cooled dextrose 5% in water.
    Cantwell CP; Wah TM; Gervais DA; Eisner BH; Arellano R; Uppot RN; Samir AE; Irving HC; McGovern F; Mueller PR
    J Vasc Interv Radiol; 2008 Jul; 19(7):1034-40. PubMed ID: 18589317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary non-small cell lung cancer: review of frequency, location, and time of recurrence after radiofrequency ablation.
    Beland MD; Wasser EJ; Mayo-Smith WW; Dupuy DE
    Radiology; 2010 Jan; 254(1):301-7. PubMed ID: 20032160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CT-guided radiofrequency ablation for hepatocellular carcinomas that were undetectable at US: therapeutic effectiveness and safety.
    Park BJ; Byun JH; Jin YH; Won HJ; Shin YM; Kim KW; Park SJ; Kim PN
    J Vasc Interv Radiol; 2009 Apr; 20(4):490-9. PubMed ID: 19328427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiofrequency ablation of pulmonary malignant tumors in nonsurgical candidates.
    Herrera LJ; Fernando HC; Perry Y; Gooding WE; Buenaventura PO; Christie NA; Luketich JD
    J Thorac Cardiovasc Surg; 2003 Apr; 125(4):929-37. PubMed ID: 12698158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.